Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SCML2 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
mRNA | ARPP21 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
mRNA | CCDC177 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
mRNA | RAB3A | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
mRNA | SLC35E2B | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
mRNA | SSBP3 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
mRNA | PAXBP1 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
mRNA | PAN2 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
mRNA | PSMD4 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-07 |
mRNA | TMOD2 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |